Advertisements
Feeds:
Posts
Comments

Search Results for 'Aspirin'

The Promise of Low-Dose Aspirin on Longevity in the Geriatric Population: No Effect on Outcomes in the US and Australia

Posted in Atherogenic Processes & Pathology, Cardiovascular Research, Coagulation Therapy and Internal Bleeding, Frontiers in Cardiology and Cardiovascular Disorders, HTN, inflammation independent of lipid levels, Pharmacotherapy of Cardiovascular Disease, Stroke on September 24, 2018| Leave a Comment »


The Promise of Low-Dose Aspirin on Longevity in the Geriatric Population: No Effect on Outcomes in the US and Australia Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 10/17/2018 https://www.nejm.org/doi/full/10.1056/NEJMoa1800722 Effect of Aspirin on Disability-free Survival in the Elderly ORIGINAL ARTICLE Effect of Aspirin on Disability-free Survival in the Healthy Elderly J.J. McNeil and Others      […]

Read Full Post »

Aspirin Advocate vs Skeptic: Any Common Ground? – Medscape

Posted in Uncategorized on November 3, 2014| Leave a Comment »


UPDATED on 7/17/2016 Aspirin Fails to Prevent Cardiovascular Events in High-Risk Patients Significant bleeding risk may outweigh any benefit Aspirin Fails to Prevent Cardiovascular Events in High-Risk Patients   Aspirin Advocate vs Skeptic: Any Common Ground? Source: login.medscape.com See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Read Full Post »

Intracranial Vascular Stenosis: Comparison of Clinical Trials: Percutaneous Transluminal Angioplasty and Stenting (PTAS) vs. Clot-inhibiting Drugs: Aspirin and Clopidogrel (dual antiplatelet therapy) – more Strokes if Stenting

Posted in Atherogenic Processes & Pathology, Cardiac and Cardiovascular Surgical Procedures, Cerebrovascular and Neurodegenerative Diseases, Innovations in Neurophysiology & Neuropsychology, PCI on October 15, 2014| 2 Comments »


Intracranial Vascular Stenosis: Comparison of Clinical Trials: Percutaneous Transluminal Angioplasty and Stenting (PTAS) vs. Clot-inhibiting Drugs: Aspirin and Clopidogrel (dual antiplatelet therapy) – more Strokes if Stenting   Reporter: Aviva Lev-Ari, PhD, RN   UPDATED on 8/5/2018 Clopidogrel plus aspirin bests aspirin alone for CV event reduction: Cochrane Source: JAMA, Published online July 26, 2018. doi:10.1001/jama.2018.9641 Curated […]

Read Full Post »

Platelet Endothelial Aggregation Receptor-1 (PEAR1) Gene to be most strongly associated with Dual Antiplatelet Therapy Response: Genetic Determinants of Variable Response to Aspirin (alone and in combination with Clopidogrel)

Posted in Atherogenic Processes & Pathology, Cardiac and Cardiovascular Surgical Procedures, Cardiovascular Pharmacogenomics, Cardiovascular Research, Cell Biology, Signaling & Cell Circuits, Chemical Genetics, Coagulation Therapy and Internal Bleeding, Computational Biology/Systems and Bioinformatics, FDA Regulatory Affairs, Frontiers in Cardiology and Cardiovascular Disorders, Genome Biology, Genomic Testing: Methodology for Diagnosis, HTN, Medical and Population Genetics, Origins of Cardiovascular Disease, PCI, Personalized and Precision Medicine & Genomic Research, Pharmacotherapy of Cardiovascular Disease, Stents & Tools, Valves & Tools, tagged , , , , , , on December 30, 2013| Leave a Comment »


Platelet Endothelial Aggregation Receptor-1 (PEAR1) Gene to be most strongly associated with Dual Antiplatelet Therapy Response: Genetic Determinants of Variable Response to Aspirin (alone and in combination with Clopidogrel) Reporter: Aviva Lev-Ari, PhD, RN 4 Genetic Variation in PEAR1 is Associated with Platelet Aggregation and Cardiovascular Outcomes Joshua P. Lewis1, Kathleen Ryan1, Jeffrey R. O’Connell1, Richard B. Horenstein1,Coleen M. Damcott1, Quince […]

Read Full Post »

PIK3CA mutation in Colorectal Cancer may serve as a Predictive Molecular Biomarker for adjuvant Aspirin therapy

Posted in Biological Networks, Gene Regulation and Evolution, Biomarkers & Medical Diagnostics, CANCER BIOLOGY & Innovations in Cancer Therapy, Cell Biology, Signaling & Cell Circuits, Chemical Biology and its relations to Metabolic Disease, Chemical Genetics, Genome Biology, Genomic Testing: Methodology for Diagnosis, Liver & Digestive Diseases Research, Medical and Population Genetics, Metabolomics, Molecular Genetics & Pharmaceutical, Personalized and Precision Medicine & Genomic Research, Population Health Management, Genetics & Pharmaceutical, tagged , , , , , , on November 28, 2012| 8 Comments »


Reporter: Aviva Lev-Ari, PhD, RN Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival N Engl J Med 2012; 367:1596-1606 October 25, 2012DOI: 10.1056/NEJMoa1207756 BACKGROUND Regular use of aspirin after a diagnosis of colon cancer has been associated with a superior clinical outcome. Experimental evidence suggests that inhibition of prostaglandin-endoperoxide synthase 2 (PTGS2) (also known as cyclooxygenase-2) by aspirin […]

Read Full Post »

Aspirin a Day Tied to Lower Cancer Mortality

Posted in CANCER BIOLOGY & Innovations in Cancer Therapy, Cell Biology, Signaling & Cell Circuits, Chemical Biology and its relations to Metabolic Disease, tagged , , , , , , on August 11, 2012| 4 Comments »


Aspirin a Day Tied to Lower Cancer Mortality Reporter: Aviva Lev-Ari, PhD, RN Aspirin a Day Tied to Lower Cancer Mortality Download Complimentary Source PDF  By Nancy Walsh, Staff Writer, MedPage Today Published: August 10, 2012 Reviewed by Zalman S. Agus, MD; Emeritus Professor, Perelman School of Medicine at the University of Pennsylvania  http://www.medpagetoday.com/HematologyOncology/OtherCancers/34149?utm_content=&utm_medium=email&utm_campaign=DailyHeadlines&utm_source=WC&eun=g99985d0r&userid=99985&email=avivalev-ari@alum.berkeley.edu&mu_id=5099207 Action Points This study […]

Read Full Post »

Tweets, ReTweets and Likes by @AVIVA1950 and by @pharma_BI using @PHSInnovation and #WMIF19 during Day One, Two and Three of World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 8-10, 2019

Posted in Conference Coverage with Social Media on April 11, 2019| Leave a Comment »


Tweets, ReTweets and Likes by @AVIVA1950 and by @pharma_BI using @PHSInnovation and #WMIF19 during Day One, Two and Three of World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 8-10, 2019 Real Time Twitter User, Daily e-Proceedings Producer at the event and Curator: Aviva Lev-Ari, PhD, RN   http://www.worldmedicalinnovation.org   Third Place in Top […]

Read Full Post »

Excerpt of 117 Followers of @AVIVA1950 (from the List of 359 Followers) by the Number of their Followers

Posted in on March 4, 2019|


Updated on 4/13/2019 Twitter Data of LPBI Group’s Founder’s Twitter handle @AVIVA1950 was updated On 2/24/2019 — Tweets 8,060 Following 1,412 Followers 359 Likes 2,752 On 4/13/2019 — Tweets 9,018 Following 1,461 Followers 390 Likes 3,654 In 48 days # Follower increases from 359 to 390 – Growth rate of 8% Three new “I” Followers […]

Read Full Post »

Aortic Stenosis (AS): Managed Surgically by Transcatheter Aortic Valve Replacement (TAVR) – Search Results for “TAVR” on NIH.GOV website, Top 16 pages

Posted in Aortic Valve: TAVR, TAVI vs Open Heart Surgery, Atherogenic Processes & Pathology, Cardiac and Cardiovascular Surgical Procedures, Congenital Heart DIsease, Frontiers in Cardiology and Cardiovascular Disorders, Medical Devices R&D and Inventions, Origins of Cardiovascular Disease, TAVI vs Open Heart Surgery, Valves & Tools on August 14, 2018| Leave a Comment »


Aortic Stenosis (AS): Managed Surgically by Transcatheter Aortic Valve Replacement (TAVR) – Search Results for “TAVR” on NIH.GOV website, Top 16 pages Reporter: Aviva Lev-Ari, PhD, RN   UPDATED on 9/24/2018 Sapien 3, CoreValve Evolut R on Par for Aortic Stenosis Head-to-head trial also shows local, general anesthesia outcomes similar by Ashley Lyles, Staff Writer, MedPage Today September 23, […]

Read Full Post »

Single-Author Reporting on MedTech and Cardiac Medical Devices by Aviva Lev-Ari, PhD, RN

Posted in on August 6, 2018|


Single-Author Reporting on MedTech and Cardiac Medical Devices by Aviva Lev-Ari, PhD, RN On 8/13/2018 Reportings, N = 150   157r  Comparison of four methods in diagnosing acute myocarditis: The diagnostic performance of native T1, T2, ECV to LLC Reporter: Aviva Lev-Ari, PhD, RN https://pharmaceuticalintelligence.com/2018/08/08/comparison-of-four-methods-in-diagnosing-acute-myocarditis-the-diagnostic-performance-of-native-t1-t2-ecv-to-llc/   156r   Left ventricular outflow tract (LVOT) obstruction (LVOTO): The Role […]

Read Full Post »

Next »